CIK 0001464521 · <br>Emerging growth company
Heartflow, Inc.
Sign in to watch- Ticker
- HTFL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260506743
- Phone
- 650-241-1221
- Business address
- 135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
- Former names
- Cardiovascular Simulation, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,602,722
- in 13 filings, $16.6M under 10b5-1 plans
Net −$16,602,722. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +40,766 | $2.22 | $91K | 138,686 |
| 2026-04-01 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +6,849 | $2.22 | $15K | 145,535 |
| 2026-04-01 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −64,533 | $24.64 | $1.6M | 81,002 |
| 2026-04-01 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Options 10b5-1 | −6,849 | 0 | ||
| 2026-04-01 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −291 | 3,298 | ||
| 2026-04-01 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −19,111 | 122,399 | ||
| 2026-04-01 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −40,766 | 81,633 | ||
| 2026-03-24 | HealthCor Partners Management LP Director | Other disposition | −4,615,542 | 0 | ||
| 2026-03-24 | Lightcap Jeffrey C Director | Other acquisition | +206,261 | 246,261 | ||
| 2026-03-19 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +19,402 | $2.22 | $43K | 95,436 |
| 2026-03-19 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +47,615 | $2.22 | $106K | 143,051 |
| 2026-03-19 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −64,533 | $25.69 | $1.7M | 78,518 |
| 2026-03-19 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −19,402 | 189,125 | ||
| 2026-03-19 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −47,615 | 141,510 | ||
| 2026-03-18 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −9,725 | $25.00 | $243K | 571,725 |
| 2026-03-11 | BARABE TIMOTHY C Director | Option exercise | +8,667 | $2.22 | $19K | 179,521 |
| 2026-03-11 | BARABE TIMOTHY C Director | Option exercise · Stock Option | −8,667 | 15,412 | ||
| 2026-03-10 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −12,837 | $22.66 | $291K | 581,450 |
| 2026-03-06 | Jones Marie L. Chief Accounting Officer | Grant or award | +1,661 | $16.15 | $27K | 33,311 |
| 2026-03-06 | Verghese Vikram Chief Financial Officer | Grant or award | +671 | $16.15 | $11K | 213,534 |
Page 6 of 12 · 224 trades